APA (7th ed.) Citation

R, V., N, P., K, D. S., E, N., R, C., T, D., . . . C, M. (2026). Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on energy metabolism and bone. Bone research, 14(1), 21. https://doi.org/10.1038/s41413-025-00503-3

Chicago Style (17th ed.) Citation

R, Valle-Tenney, et al. "Pharmacological HIF Activation Protects Against Diet-induced Obesity, Glucose Intolerance, and Skeletal Dysfunction by Exerting Dual Beneficial Effects on Energy Metabolism and Bone." Bone Research 14, no. 1 (2026): 21. https://doi.org/10.1038/s41413-025-00503-3.

MLA (9th ed.) Citation

R, Valle-Tenney, et al. "Pharmacological HIF Activation Protects Against Diet-induced Obesity, Glucose Intolerance, and Skeletal Dysfunction by Exerting Dual Beneficial Effects on Energy Metabolism and Bone." Bone Research, vol. 14, no. 1, 2026, p. 21, https://doi.org/10.1038/s41413-025-00503-3.